	Multi-omics integration of molecular genetics, cytogenetics and immunophenotyping: a novel prognostic model for immune landscape characterization and outcome prediction in Chinese patients with acute myeloid leukemia. Front Immunol Li F, Ding Y, Feng S, Jin Y, Xie B, Zhang Q, Jiao X, Zhu J, Zhang W, Tao Q, Wang H, Wu D, Liu X, Zhai Z. PMID: 42148074 [PubMed - indexed for MEDLINE]
	Peritoneal Lymphomatosis Mimicking Advanced Ovarian Malignancy: A Diagnostic Challenge in Diffuse Large B-Cell Lymphoma. Cureus Kyeremateng D, Umelue L, Black M, Ndlovu C. PMID: 42147565 [PubMed]
	Clinico-Hematological and Immunophenotypic Profile of Leukemia Patients at a Tertiary Care Center in Jharkhand, India: A Cross-Sectional Study. Cureus Shome A, Paswan MK, Jamaiyar A, Shome A. PMID: 42147558 [PubMed]
	Unraveling novel therapeutic targets for diffuse large B-cell lymphoma: a plasma multi-omics study. Front Pharmacol Sun X, Kang K, Wu Y, Yang Y, Wang L, Liu Y, Huo L, Niu T, Zhao A. PMID: 42147334 [PubMed]
	Optimized deep learning ensemble using Fast Osprey algorithm for accurate lymphoblastic leukemia detection. Front Med (Lausanne) Kaur N, Khan S, Kaur B, Alomran A, Ahmad S, Alshammari T, Alomary FO. PMID: 42145727 [PubMed]
	Pharmacokinetics, Efficacy, and Safety Profiles of Mitoxantrone Hydrochloride Liposome Plus Cytarabine in Pediatric Patients With Newly Diagnosed Acute Myeloid Leukemia. Pediatr Blood Cancer Yang W, Zhang R, Li X, Liu L, Zhang A, Liu T, Wang S, Qi B, Hu T, Chen Y, Chen X, Guo Y, Zhang Y, Li T, Zhu X. PMID: 42145023 [PubMed - as supplied by publisher]
	Integrated Molecular Risk Stratification and Measurable Residual Disease-Guided Consolidation Improve Outcomes in Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia. Cancer Med Cai C, Chen Y, Wu C, Feng X, Li C, Zheng M, Mai H, Yang L, Jiang H, He X, Wen H, Xu H, Chen C, Le S, Li N, Zheng Y. PMID: 42144574 [PubMed - indexed for MEDLINE]
	CAR T-Cell Therapy in Patients With Primary Central Nervous System Lymphoma: A LOC Network Study. Am J Hematol Bouille F, Baron M, Houot R, Chapelle R, Soussain C, Ursu R, Waultier-Rascalou A, Guffroy B, Ahle G, Willems L, Blonski M, Morschhauser F, Gastinne T, Paillassa J, Moluçon-Chabrot C, Schenone L, Gyan E, Hoang-Xuan K, Choquet S, Houillier C. PMID: 42144288 [PubMed - as supplied by publisher]
	Single-Cell RNA Sequencing Unveils CD8(+) T Cell Heterogeneity in the Diffuse Large B-cell Lymphoma Microenvironment: A Systematic Review. Crit Rev Oncol Hematol Maimaiti A, Xiaolong QI, Zhang Z, Yan LI. PMID: 42144172 [PubMed - as supplied by publisher]
	Pediatric laryngeal lymphoma: A systematic review of clinical presentation, management, and outcomes. Int J Pediatr Otorhinolaryngol Boot M, Niles N, Lee J. PMID: 42143904 [PubMed - as supplied by publisher]
	Licochalcone A targets ADRB2 to enhance CD8(+) T cell anti-leukemia activity via regulation involving the AKT2/FOXO1/GLUT2 axis. Pathol Res Pract Han P, Wang H, Cai Y, Sun Y, Zhou D. PMID: 42143558 [PubMed - as supplied by publisher]
	SOHO State of the Art Updates and Next Questions \| Management of Primary Central Nervous System Lymphoma. Clin Lymphoma Myeloma Leuk Fiore P, Calimeri T, Ferreri AJM. PMID: 42142971 [PubMed - as supplied by publisher]
	Challenges in the treatment of adolescent and young adult acute lymphoblastic leukemia: A comprehensive review. Blood Rev Burkart M, Dinner S. PMID: 42142954 [PubMed - as supplied by publisher]
	Impact of the changes in chronic myeloid leukemia classification proposed by the 2022 World Health Organization: a single-center Brazilian study. Hematol Transfus Cell Ther Emiliano EG, Santos GEAA, Miranda ECM, Duarte GBO, Amarante GBD, De Souza CA, Pagnano KBB. PMID: 42142415 [PubMed - as supplied by publisher]
	An interpretable PET/CT-based radiomic-clinical model for predicting bone marrow involvement in follicular lymphoma: comparison of pelvic and spine-pelvis VOI frameworks. Eur J Nucl Med Mol Imaging Li SC, Xu YP, He F, Chen QL, Li AM, Fan X, He J. PMID: 42142271 [PubMed - as supplied by publisher]
	Comparative and integrated application of flow cytometry and next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia. Ann Hematol Huang J, Zheng C, Liu Y, Li C, Xin X. PMID: 42142121 [PubMed - as supplied by publisher]
	Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia. Hematol Oncol Medawar G, Anoma JS, Hill E, Tharakan S, Sastow DL, Lok V, Hahn SB, Chen S, Kehoe T, Ramasamy C, Guetta-Weiss J, Meleveedu K, Lin C, Swoboda DM, Tremblay D, Coltoff A. PMID: 42142041 [PubMed - indexed for MEDLINE]
	Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice. Br J Haematol Goodall E, Palmer J, Martynchyk A, Waters N, Swain F, Giang TB, Marconi T, Brennan J, Gregory GP, Cheah C, Keane C, Hawkes EA. PMID: 42141736 [PubMed - as supplied by publisher]
	CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical Study. HLA Zheng H, Zhao H, Zhu X, Feng J, Wei G, Han S, Huang S, Cui J, Fu S, Zhang M, Zhang Y, Shi J, Luo Y, Chang AH, Hu Y, Huang H. PMID: 42141373 [PubMed - indexed for MEDLINE]
	Metabolic vulnerabilities and therapeutic opportunities in diffuse large B-cell lymphoma. Oncogenesis Neumann MA, Frezza C. PMID: 42140916 [PubMed]

Articles 1 - 20 / 167768

Page 1 of 8389



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy